Published in Dis Colon Rectum on September 01, 2016
Tailored Treatment of Colorectal Cancer: Surgical, Molecular, and Genetic Considerations. Clin Med Insights Oncol (2017) 0.75
Long-range heterogeneity at the 3' ends of human mRNAs. Genome Res (2002) 3.91
Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg (2004) 3.50
High-throughput SELEX SAGE method for quantitative modeling of transcription-factor binding sites. Nat Biotechnol (2002) 3.04
Avoiding radical surgery improves early survival in elderly patients with rectal cancer, demonstrating complete clinical response after neoadjuvant therapy: results of a decision-analytic model. Dis Colon Rectum (2015) 2.67
Swine and poultry pathogens: the complete genome sequences of two strains of Mycoplasma hyopneumoniae and a strain of Mycoplasma synoviae. J Bacteriol (2005) 2.15
CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens. Nucleic Acids Res (2008) 2.14
Fasting breath hydrogen concentration in short bowel syndrome patients with colon incontinuity before and after antibiotic therapy. Nutrition (2004) 2.01
Nineteen additional unpredicted transcripts from human chromosome 21. Genomics (2002) 1.80
The generation and utilization of a cancer-oriented representation of the human transcriptome by using expressed sequence tags. Proc Natl Acad Sci U S A (2003) 1.79
Approaching a complete repository of sequence-verified protein-encoding clones for Saccharomyces cerevisiae. Genome Res (2007) 1.75
Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy. J Gastrointest Surg (2006) 1.68
Transanal endoscopic microsurgery for residual rectal cancer (ypT0-2) following neoadjuvant chemoradiation therapy: another word of caution. Dis Colon Rectum (2013) 1.64
Optimal timing for assessment of tumor response to neoadjuvant chemoradiation in patients with rectal cancer: do all patients benefit from waiting longer than 6 weeks? Int J Radiat Oncol Biol Phys (2012) 1.62
Maternal embryonic leucine zipper kinase transcript abundance correlates with malignancy grade in human astrocytomas. Int J Cancer (2008) 1.54
Is tailoring treatment of rectal cancer the only true benefit of long-course neoadjuvant chemoradiation? Dis Colon Rectum (2013) 1.49
Complete clinical response after neoadjuvant chemoradiation therapy for distal rectal cancer: characterization of clinical and endoscopic findings for standardization. Dis Colon Rectum (2010) 1.45
Mitochondria as a source of reactive oxygen and nitrogen species: from molecular mechanisms to human health. Antioxid Redox Signal (2013) 1.43
Watch and wait approach following extended neoadjuvant chemoradiation for distal rectal cancer: are we getting closer to anal cancer management? Dis Colon Rectum (2013) 1.40
Interval between surgery and neoadjuvant chemoradiation therapy for distal rectal cancer: does delayed surgery have an impact on outcome? Int J Radiat Oncol Biol Phys (2008) 1.38
The role of carcinoembriogenic antigen in predicting response and survival to neoadjuvant chemoradiotherapy for distal rectal cancer. Dis Colon Rectum (2009) 1.33
Sense-antisense pairs in mammals: functional and evolutionary considerations. Genome Biol (2007) 1.26
Long-term results of preoperative chemoradiation for distal rectal cancer correlation between final stage and survival. J Gastrointest Surg (2005) 1.22
The impact of SNPs on the interpretation of SAGE and MPSS experimental data. Nucleic Acids Res (2004) 1.19
Nonoperative approaches to rectal cancer: a critical evaluation. Semin Radiat Oncol (2011) 1.17
Loop ileostomy morbidity: timing of closure matters. Dis Colon Rectum (2006) 1.15
Epigenetic silencing of CRABP2 and MX1 in head and neck tumors. Neoplasia (2009) 1.14
Colorectal cancer "methylator phenotype": fact or artifact? Neoplasia (2005) 1.13
Mucinous colorectal adenocarcinoma: influence of mucin expression (Muc1, 2 and 5) on clinico-pathological features and prognosis. Int J Colorectal Dis (2008) 1.12
DNA ploidy status and prognosis in colorectal cancer: a meta-analysis of published data. Dis Colon Rectum (2007) 1.12
Random X inactivation and extensive mosaicism in human placenta revealed by analysis of allele-specific gene expression along the X chromosome. PLoS One (2010) 1.11
Anorectal leiomyomas: report of two cases with different anatomical patterns and literature review. Rev Hosp Clin Fac Med Sao Paulo (2004) 1.10
Gluteal and perianal hidradenitis suppurativa: surgical treatment by wide excision. Dis Colon Rectum (2003) 1.09
Gene copy-number polymorphism caused by retrotransposition in humans. PLoS Genet (2013) 1.09
Generation of longer 3' cDNA fragments from massively parallel signature sequencing tags. Nucleic Acids Res (2004) 1.07
Brazilian consensus on gastroesophageal reflux disease: proposals for assessment, classification, and management. Am J Gastroenterol (2002) 1.07
Incidence and management of perineal hernia after laparoscopic proctectomy. Surg Laparosc Endosc Percutan Tech (2005) 1.06
Complications of gastrectomy with lymphadenectomy in gastric cancer. Gastric Cancer (2004) 1.06
Methylation profile of genes CDKN2A (p14 and p16), DAPK1, CDH1, and ADAM23 in head and neck cancer. Cancer Genet Cytogenet (2007) 1.05
Digestive tract microbiota in healthy volunteers. Clinics (Sao Paulo) (2007) 1.03
Laparoscopic versus standard appendectomy outcomes and cost comparisons in the private sector. J Gastrointest Surg (2005) 1.03
Lymph node size in rectal cancer following neoadjuvant chemoradiation--can we rely on radiologic nodal staging after chemoradiation? Dis Colon Rectum (2009) 1.03
Shifting concepts in rectal cancer management: a review of contemporary primary rectal cancer treatment strategies. CA Cancer J Clin (2012) 1.02
The main hepatic anatomic variations for the purpose of split-liver transplantation. Hepatogastroenterology (2007) 1.02
Conventional approach x laparoscopic abdominoperineal resection for rectal cancer treatment after neoadjuvant chemoradiation: results of a prospective randomized trial. Rev Hosp Clin Fac Med Sao Paulo (2003) 1.02
Epigenetic silencing of the adhesion molecule ADAM23 is highly frequent in breast tumors. Oncogene (2004) 1.02
Increasing the rates of complete response to neoadjuvant chemoradiotherapy for distal rectal cancer: results of a prospective study using additional chemotherapy during the resting period. Dis Colon Rectum (2009) 1.01
Systematic detection of putative tumor suppressor genes through the combined use of exome and transcriptome sequencing. Genome Biol (2010) 1.01
Combined resection of the duodenum and pancreas for locally advanced colon cancer. Curr Surg (2005) 1.01
Megaesophagus microbiota: a qualitative and quantitative analysis. J Gastrointest Surg (2002) 1.00
[Evaluation of quality of life in anal incontinence: validation of the questionnaire FIQL (Fecal Incontinence Quality of Life)]. Arq Gastroenterol (2005) 0.99
ADAM23 negatively modulates alpha(v)beta(3) integrin activation during metastasis. Cancer Res (2009) 0.98
Lymph node micrometastasis in stage II distal rectal cancer following neoadjuvant chemoradiation therapy. Int J Colorectal Dis (2005) 0.97
SATR-1 hypomethylation is a common and early event in breast cancer. Cancer Genet Cytogenet (2006) 0.96
Brazilian consensus in gastric cancer: guidelines for gastric cancer in Brazil. Arq Bras Cir Dig (2013) 0.96
Simultaneous CXCL12 and ESR1 CpG island hypermethylation correlates with poor prognosis in sporadic breast cancer. BMC Cancer (2010) 0.96
Complete clinical response after neoadjuvant chemoradiation for distal rectal cancer. Surg Oncol Clin N Am (2010) 0.94
ADAM33 gene silencing by promoter hypermethylation as a molecular marker in breast invasive lobular carcinoma. BMC Cancer (2009) 0.93
Epigenetic changes of CXCR4 and its ligand CXCL12 as prognostic factors for sporadic breast cancer. PLoS One (2011) 0.93
Transanal endoscopic microsurgery for residual rectal cancer after neoadjuvant chemoradiation therapy is associated with significant immediate pain and hospital readmission rates. Dis Colon Rectum (2011) 0.93
Tissue distribution of quiescin Q6/sulfhydryl oxidase (QSOX) in developing mouse. J Mol Histol (2007) 0.92
Genetic diversity of Leishmania amazonensis strains isolated in northeastern Brazil as revealed by DNA sequencing, PCR-based analyses and molecular karyotyping. Kinetoplastid Biol Dis (2007) 0.90
Insights into gliomagenesis: systems biology unravels key pathways. Genome Med (2009) 0.90
Reduced transcription of TCOF1 in adult cells of Treacher Collins syndrome patients. BMC Med Genet (2009) 0.90
Anatomic study of gastric vascularization and its relationship to cervical gastroplasty. J Gastrointest Surg (2005) 0.89
A transcript finishing initiative for closing gaps in the human transcriptome. Genome Res (2004) 0.89
Conservative therapies for hemorrhagic radiation proctitis: a review. Rev Hosp Clin Fac Med Sao Paulo (2003) 0.88
Distinct patterns of somatic alterations in a lymphoblastoid and a tumor genome derived from the same individual. Nucleic Acids Res (2011) 0.88
Cardiaplasty and Roux-en-Y partial gastrectomy (Serra-Dória procedure) for reoperation of achalasia. Arq Gastroenterol (2005) 0.88
Characterization of a cancer/testis (CT) antigen gene family capable of eliciting humoral response in cancer patients. Proc Natl Acad Sci U S A (2006) 0.87
Echo-endoscopy versus endoscopic retrograde cholangiography for the diagnosis of choledocholithiasis: the influence of the size of the stone and diameter of the common bile duct. Arq Gastroenterol (2006) 0.86
Inflammatory bowel diseases: principles of nutritional therapy. Rev Hosp Clin Fac Med Sao Paulo (2002) 0.86
Biofeedback therapy in the colon and rectal practice. Appl Psychophysiol Biofeedback (2003) 0.85
Familial gastric cancer. Arq Gastroenterol (2004) 0.85
Clinicopathologic and immunohistochemistry characterization of synchronous multiple primary gastric adenocarcinoma. J Gastrointest Surg (2007) 0.85
Cowden syndrome: report of two cases and review of clinical presentation and management of a rare colorectal polyposis. Curr Surg (2005) 0.85
Prospective multicenter trial comparing echodefecography with defecography in the assessment of anorectal dysfunction in patients with obstructed defecation. Dis Colon Rectum (2011) 0.85
Does the intraoperative peritoneal lavage cytology add prognostic information in patients with potentially curative gastric resection? J Gastrointest Surg (2006) 0.84
Local excision for ypT2 rectal cancer--much ado about something. J Gastrointest Surg (2007) 0.84
New surgical options for fecal incontinence in patients with imperforate anus. Dis Colon Rectum (2004) 0.83
[Extracolonic manifestations of familial adenomatous polyposis: incidence and impact on the disease outcome]. Arq Gastroenterol (2004) 0.83
Targeting MAGE-C1/CT7 expression increases cell sensitivity to the proteasome inhibitor bortezomib in multiple myeloma cell lines. PLoS One (2011) 0.83